Status:
NOT_YET_RECRUITING
Articular Damage in Patients With Juvenile Idiopathic Arthritis After Transition to Adult Care
Lead Sponsor:
IRCCS Burlo Garofolo
Conditions:
Juvenile Chronic Arthritis
Eligibility:
All Genders
16-25 years
Brief Summary
Juvenile idiopathic arthritis (JIA) is the most common childhood chronic rheumatic disease, encompassing all forms of arthritis that persist for more than 6 weeks, with onset before age 16, after excl...
Eligibility Criteria
Inclusion
- Patients aged between 16 to 25 years who received a diagnosis of JIA in pediatric age according to International League of Associations for Rheumatology criteria (2001) and who have begun the process of transition to adult care.
- Young adults undergoing healthcare transition process from the the pediatric to adult rheumatology since 2016.
- Patients with radiological evidence of joint plates closure.
- X-ray images of hands, hips, and knees available
Exclusion
- Patients cared at the adult rheumatology clinic who received a diagnosis of arthritis in the adult age.
- Patients with other orthopedic conditions or affected by other diseases leading to osteoporosis or skeletal deformities.
- Patients affected by other rheumatological conditions who underwent healthcare transition process from the the pediatric to adult rheumatology center.
Key Trial Info
Start Date :
April 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06895278
Start Date
April 1 2025
End Date
December 31 2025
Last Update
March 26 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda sanitaria di Reggio Emilia - Arcispedale Santa Maria Nuova
Reggio Emilia, Italia, Italy, 42122
2
IRCCS Materno Infantile "Burlo Garofolo"
Trieste, Italia, Italy, 34100
3
Istituto Azienda sanitaria universitaria Friuli Occidentale - Ospedale "Santa Maria della Misericordia"
Udine, Italia, Italy, 33100